Galderma Group AG engages in the provision of science-based premium dermatology solutions. The company is headquartered in Zug, Zug. The company went IPO on 2024-03-22. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Follow-Up Questions
Galderma Group AG 'in CEO'su kimdir?
Dr. Flemming Ornskov 2019 'den beri şirketle birlikte olan Galderma Group AG 'in Chief Executive Officer 'ıdır.
GALDY hissesinin fiyat performansı nasıl?
GALDY 'in mevcut fiyatı $35.15 'dir, son işlem günde 0% decreased etti.
Galderma Group AG için ana iş temaları veya sektörler nelerdir?
Galderma Group AG Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Galderma Group AG 'in piyasa değerlemesi nedir?
Galderma Group AG 'in mevcut piyasa değerlemesi $41.2B 'dir
Galderma Group AG al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 16 analist Galderma Group AG için analist derecelendirmeleri gerçekleştirdi, bunlar 6 güçlü al, 9 al, 4 tut, 0 sat ve 6 güçlü sat içermektedir
